Filing Details
- Accession Number:
- 0001651844-19-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-02 11:33:12
- Reporting Period:
- 2019-07-01
- Accepted Time:
- 2019-07-02 11:33:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-01 | 2,200 | $1.37 | 3,472,750 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 4,806 | $1.37 | 3,477,556 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 800 | $1.36 | 3,478,356 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 295 | $1.37 | 3,478,651 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 28 | $1.37 | 3,478,679 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 100 | $1.37 | 3,478,779 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 371 | $1.36 | 3,479,150 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 400 | $1.36 | 3,479,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |